Navigation Links
Increase of Cancer drug usage in England

A recent report reveals the drastic rise in cancer drug usage and reduction in "postcode prescribing" in England.//

Mike Richards, the National Cancer Director, will be announcing the numbers that reveal huge differences in prescribing over a short time, i.e., from 2003 second half to 2005 first half.

Charities and drug companies condemned that cancer drugs were not being extensively used in spite of getting approval from the National Institute for Health and Clinical Excellence (NICE). This curtailed Professor Richards's investigation.

According to Professor Richards’ report in June 2004, various regional cancer networks showed notable difference in the uptake of drugs. Professor made suggestions to decrease these differences and to ensure wide supply of good drugs.

According to him, the subsequent study has shown significant improvement. There is a drastic rise in the cancer drug usage in the 18 months gap between the two surveys. Two-fold increase in usage of some drugs, like rituximab (MabThera), for lymphoma, and temozolomide (Temodal), for the brain cancer glioma, were seen usage in that period. The use of trastuzumab (Herceptin), for breast cancer, went up by 55 %, and imatinib (Glivec), for chronic myeloid leukaemia, by 70 %.

"For every single cancer drug, we are seeing a reduction in the variation," Professor Richards said. "We haven't eliminated all variation but we are moving in the right direction and the recommendations of the first report are beginning to pay off."

Some of the differences are due to individual clinicians' judgments, some to the patient mix in an area, or the sending of particular types of patient to a different area for treatment.
"But taking all that into account, this is good news," he said. "We are moving in the right direction." Rosie Winterton, the Health Minister, welcomed the report. "It is fundamental that all cancer patients s hould have the same access to cancer drugs that have been approved by NICE, no matter where they live," she said.

"I am delighted that the cancer director's report shows that considerable progress has been made. "However, that does not mean we will be complacent - we recognise that there is still more to do. As more people are diagnosed with cancer each year, the NHS must keep improving cancer services so each and every patient receives the best treatment possible."

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Increase in renal problems
10. Fewer teeth & Increased Ischemic Stroke risk
11. Painkillers Increase Risk of Miscarriage
Post Your Comments:

(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
Breaking Medicine Technology: